ANCA-Associated Vasculitis, An Issue of Rheumatic Disease Clinics, 1st Edition
Authors :
Barrie J. Fessler & S. Louis Bridges Jr.
This issue of the Rheumatic Disease Clinics of North America provides the rheumatologist with the latest information on diagnosis and treatment of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Topics covered inlucde epidemiolog ...view more
This issue of the Rheumatic Disease Clinics of North America provides the rheumatologist with the latest information on diagnosis and treatment of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Topics covered inlucde epidemiology; history; pathogenesis; autoantibodies in ANCA-associated vasculitis (including drug-induced ANCAs); pauci-immune renal disease; ocular manifestations; diagnostic approach (including mimickers); Wegener’s Granulomatosis; Churg-Strauss Syndrome; microscopic polyangiitis; outcome measures; and the future of ANCA-Associated Vasculitis.
This issue of the Rheumatic Disease Clinics of North America provides the rheumatologist with the latest information on diagnosis and treatment of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Topics covered inlucde epidemiology; history; pathogenesis; autoantibodies in ANCA-associated vasculitis (including drug-induced ANCAs); pauci-immune renal disease; ocular manifestations; diagnostic approach (including mimickers); Wegener’s Granulomatosis; Churg-Strauss Syndrome; microscopic polyangiitis; outcome measures; and the future of ANCA-Associated Vasculitis.
Author Information
By Barrie J. Fessler, MD,MSPH and S. Louis Bridges Jr., MD, PhD, University of Alabama at Birmingham
https://www.us.elsevierhealth.com/anca-associated-vasculitis-an-issue-of-rheumatic-disease-clinics-9781437724936.html6399ANCA-Associated Vasculitis, An Issue of Rheumatic Disease Clinicshttps://www.us.elsevierhealth.com/media/catalog/product/9/7/9781437724936.jpg69.2998.99USDInStock/Medicine/Rheumatology/Clinics/Clinics174388725525504113841826925145120This issue of the Rheumatic Disease Clinics of North America provides the rheumatologist with the latest information on diagnosis and treatment of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Topics covered inlucde epidemiology; history; pathogenesis; autoantibodies in ANCA-associated vasculitis (including drug-induced ANCAs); pauci-immune renal disease; ocular manifestations; diagnostic approach (including mimickers); Wegener’s Granulomatosis; Churg-Strauss Syndrome; microscopic polyangiitis; outcome measures; and the future of ANCA-Associated Vasculitis. This issue of the Rheumatic Disease Clinics of North America provides the rheumatologist with the latest information on diagnosis and treatment of antineutrophil cytoplasmic antibodies (ANCA)-associated vasculitis. Topics covered inlucde epidemiology; history; pathogenesis; autoantibodies in ANCA-associated vasculitis (including drug-induced ANCAs); pauci-immune renal disease; ocular manifestations; diagnostic approach (including mimickers); Wegener’s Granulomatosis; Churg-Strauss Syndrome; microscopic polyangiitis; outcome measures; and the future of ANCA-Associated Vasculitis.00add-to-cart97814377249362011 and earlierProfessionalBy Barrie J. Fessler, MD,MSPH and S. Louis Bridges Jr., MD, PhD20101Book152w x 229h (6.00" x 9.00")Saunders0Aug 30, 2010IN STOCK - This may take up to 5 business days to shipBy <STRONG>Barrie J. Fessler</STRONG>, MD,MSPH and <STRONG>S. Louis Bridges Jr.</STRONG>, MD, PhD, University of Alabama at BirminghamClinicsClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
